[Gastric uptake of gallium67 in the human immunodeficiency virus infection].
D017088:AIDS-Related Opportunistic Infections / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000382:microbiology; D000328:Adult; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002254:Carbonates / Q000627:therapeutic use; D004724:Endoscopy; D005260:Female; D005710:Gallium Radioisotopes; D005753:Gastric Mucosa / Q000000981:diagnostic imaging*; D005767:Gastrointestinal Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000382:microbiology; D016481:Helicobacter Infections / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D008297:Male; D009853:Omeprazole / Q000627:therapeutic use; D011877:Radionuclide Imaging; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D002254:Carbonates; D005710:Gallium Radioisotopes; C043698:almagate; D000536:Aluminum Hydroxide; D009853:Omeprazole; D008276:Magnesium Hydroxide
Captación gástrica de Galio67 en la infección por virus de la inmunodeficiencia humana.